We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The House Energy and Commerce Committee voted 54-0 on June 7 to advance the FDA’s five-year user fee reauthorization package to the floor of the House — with several new amendments on devices. Read More